In the last year, some drugmakers have pulled back from the sector, including Pfizer, which recently stopped selling its gene ...
Novartis (NVS) announced that oral Fabhalta, iptacopan, has received U.S. Food and Drug Administration approval for the ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration ...
By Paul Arnold and Maggie Fick ZURICH (Reuters) -Swiss drugmaker Novartis is ending its use of diverse panels for all of its ...
ZURICH (Reuters) -Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its ...
Today, Folia Health and Novartis Pharmaceuticals, Inc. proudly announce their collaboration on an innovative, at-home observational real-world evidence initiative supporting individuals with IgA ...
NEW YORK (Reuters) -The National Football League has signed its first-ever pharmaceutical partner in a multi-year deal with ...
GSK and Vertex Pharmaceuticals, two of the rare major ... support for programs backing young women in STEM and more. Novartis and Bayer, too, used IWD to shed light on the gender health gap.
Novartis (NOVN: VX) has reported new data showing that its ... These improvements in sleep add to the drug’s strong efficacy profile, with the Swiss pharma giant having already reported that ...
This year, drugmakers leaning into this space included the likes of Novo Nordisk, Novartis and Eli Lilly — which debuted its Healthy Skeptic spot days before the broadcast. Among the dozens of ads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback